Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

FDA says new test finds ‘unacceptable levels’ of impurity in heartburn drugs

The FDA found “unacceptable levels” of a cancer-causing impurity in limited testing using low-heat method of samples of heartburn medicines such as Zantac containing the ingredient ranitidine.

Read More »

Johnson & Johnson settles Ohio lawsuits to avoid federal trial

Johnson & Johnson will pay $20.4 million to settle claims by two Ohio counties, allowing the U.S. healthcare giant to avoid an upcoming federal trial seeking to hold the industry responsible for the nation’s opioid epidemic.

Read More »

Drug companies urge appeals court to remove judge from U.S. opioid litigation

Eight drug companies urged a federal appeals court to disqualify the judge overseeing nationwide opioid litigation, in a last-ditch effort to avoid having him preside over a landmark trial.

Read More »

Three Retail Pharmacies Suspend Sales of Zantac

In the wake of the discovery that some Zantac products may contain a carcinogen contaminant due to the manufacturing process, drug store retailers removed the antacid from shelves.

Read More »

Sweden’s Sobi to Acquire Dova Pharmaceuticals

Shares of Dova Pharmaceuticals were up more than 38 percent after Sweden-based Sobi announced the intended acquisition of the North Carolina-based company for $915 million.

Read More »

Ian Read to Step Down as Pfizer Chairman

Ian Read, a stalwart figure at Pfizer for four decades, will step down from his role as executive chairman of the board of directors at the end of 2019.

Read More »

U.S. agents search Clio Laboratories in fraud probe

U.S. federal agents executed a warrant to search the Clio Laboratories in Georgia as part of a nationwide crackdown into genetic testing fraud against federal health insurance programs.

Read More »

Mylan to pay $30 million U.S. SEC fine related to EpiPen overcharge probe

Mylan NV agreed to settle U.S. SEC charges that the company hid from investors the impact of a federal probe into the drugmaker’s overbilling the government for the EpiPen allergy treatment.

Read More »

House panel asks e-cig companies to cease advertising

A U.S. House panel sent letters to four e-cigarette companies asking them to stop all print, broadcast and digital advertising of their products in the United States.

Read More »

Juul Labs suspends advertising in U.S., replaces CEO

Juul Labs said the company would suspend all broadcast, print and digital product advertising in the United States and replaced CEO Kevin Burns.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!


Ad Right Bottom